| CAT No: | CL-PGZN-05 |
| CAS No: | 952188-00-0 |
| Mol.F: | C28H31N3O3S |
| Mol.Wt.: | 489.6 |
| Chemical Name: | (5RS)-5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione ; (?)-5-{4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl}-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione (as per USP) |
| Inventory Status: | Custom synthesis |
This impurity is related to Pioglitazone EP Impurity C is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Pioglitazone EP Impurity C is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(5RS)-5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione ; (?)-5-{4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl}-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione (as per USP)Country of Origin: India Product Category: Impurity Reference StandardAPI NAME: Pioglitazone Molecular Formula: C28H31N3O3S
Molecular Weight: 489.6
Storage: Store in a cool, dry place.
| Product Name: | Pioglitazone EP Impurity C |
| CAS No: | 952188-00-0 |
| Mol.F.: | C28H31N3O3S |
| Mol.Wt.: | 489.6 |
Cat. No: CL-PGZN-01
CAS No: 111025-46-8
Mol. F: C19H20N2O3S
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-02
CAS No: 112529-15-4
Mol. F: C19H20N2O3S : HCl
Mol. Wt: 356.4 : 36.5
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-03
CAS No: 625853-74-9
Mol. F: C19H20N2O4S
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-04
CAS No: 136401-69-9
Mol. F: C19H18N2O3S
Mol. Wt: 354.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-06
CAS No: 868754-41-0
Mol. F: C21H26N2O4S
Mol. Wt: 402.5
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-07
CAS No: 868754-42-1
Mol. F: C20H25NO3
Mol. Wt: 327.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-08
CAS No: 1391052-15-5
Mol. F: C20H16N2O5S2
Mol. Wt: 428.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-09
CAS No: 952187-99-4
Mol. F: C34H35N3O4S
Mol. Wt: 581.7
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-10
CAS No: 114393-97-4
Mol. F: C16H17NO2
Mol. Wt: 255.3
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-11
CAS No: 85583-40-0
Mol. F: C15H18N2O
Mol. Wt: 242.3
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-12
CAS No: 669716-58-9
Mol. F: C15H16BrNO
Mol. Wt: 306.2
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-13
CAS No: 646519-84-8
Mol. F: C19H18N2O4S
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-14
CAS No: 291536-42-0
Mol. F: C10H8FNO2S
Mol. Wt: 225.2
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-15
CAS No: 471295-98-4
Mol. F: C16H17NO3
Mol. Wt: 271.3
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-16
CAS No: 105355-26-8
Mol. F: C19H21N3O2S
Mol. Wt: 355.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-17
CAS No: 74772-78-4
Mol. F: C10H9NO3S
Mol. Wt: 223.2
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-18
CAS No: 101931-00-4
Mol. F: C19H20N2O4S
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-19
CAS No: 146062-45-5
Mol. F: C19H20N2O4S
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-20
CAS No: 146062-44-4
Mol. F: C19H20N2O4S
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-21
CAS No: 146062-48-8
Mol. F: C19H18N2O5S
Mol. Wt: 386.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-22
CAS No: 145350-09-0
Mol. F: C19H20N2O4S
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-23
CAS No: 669716-56-7
Mol. F: C34H35N3O4S
Mol. Wt: 581.7
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-24
CAS No: 625853-73-8
Mol. F: C18H22N2O5S
Mol. Wt: 378.4
Inv. Status: Custom Synthesis
Cat. No: CL-PGZN-25
CAS No: 2295-31-0
Mol. F: C3H3NO2S
Mol. Wt: 117.1
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: